Dmitry Balyasny’s Dr. Reddy's Laboratories RDY Stock Holding History

Dmitry Balyasny’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$894K	Buy	+61,707	New	+$832K	﹤0.01%	2274
2025 Q3	–	Sell	-334,294	Closed	-$5.02M	–	3382
2025 Q2	$5.02M	Buy	+334,294	New	+$4.77M	0.01%	1294
2025 Q1	–	Sell	-103,850	Closed	-$1.64M	–	3204
2024 Q4	$1.64M	Buy	103,850 +44,955	+76%	+$675K	﹤0.01%	1748
2024 Q3	$936K	Buy	+58,895	New	+$948K	﹤0.01%	1996
2024 Q2	–	Sell	-76,890	Closed	-$1.13M	–	3009
2024 Q1	$1.13M	Buy	76,890 +40,205	+110%	+$587K	﹤0.01%	1736
2023 Q4	$511K	Sell	36,685 -31,880	-46%	-$426K	﹤0.01%	1946
2023 Q3	$917K	Sell	68,565 -16,715	-20%	-$226K	﹤0.01%	1587
2023 Q2	$1.08M	Buy	+85,280	New	+$996K	﹤0.01%	1593
2022 Q4	–	Sell	-28,730	Closed	-$301K	–	3156
2022 Q3	$301K	Buy	+28,730	New	+$306K	﹤0.01%	2194
2018 Q4	–	Sell	-139,995	Closed	-$969K	–	1693
2018 Q3	$969K	Buy	+139,995	New	+$936K	﹤0.01%	1187

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dmitry Balyasny's RDY Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 61,707 shares worth $894K. The stake represents ﹤0.01% of the portfolio and ranks #2274 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in RDY as recently as Q2 2025.

Dmitry Balyasny first reported a position in RDY in Q3 2018 and has held it in 10 quarters since. The position peaked at $5.02M in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Dmitry Balyasny held 61,707 shares of Dr. Reddy's Laboratories worth $894K as of Q2 2026.
Dr. Reddy's Laboratories was a new Dmitry Balyasny position in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2274 holding.
Dmitry Balyasny first reported a position in Dr. Reddy's Laboratories in Q3 2018 and has held it in 10 quarters since.
Dmitry Balyasny's Dr. Reddy's Laboratories position peaked at $5.02M in Q2 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.